(S)-Methyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate

Intermediate for Carfilzomib. Carfilzomib (trade name: Kyprolis) is an anti-cancer drug acting as a selective proteasome inhibitor. Carfilzomib has been approved by the U.S Food and Drug Administration on July 20, 2012.

Specifications

Product Name:                  (S)-Methyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate

Synonyms:                         N/A

CAS Number:                     1140908-89-9

Molecular Weight:            580.7228

Molecular Formula:          C32H44N4O6

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C(CN2CCOCC2)N[C@H](C(N[C@H](C(N[C@H](C(OC)=O)CC3=CC=CC=C3)=O)CC(C)C)=O)CCC1=CC=CC=C1

(S)-Methyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate

  • $800.00
  • Ex Tax: $800.00

Available Options